Friday, June 18, 2021

Paradigm reports 65% pain reduction in OA patients treated under the US FDA expanded...

0
Paradigm submitted an Expanded Access Investigational new drug application (IND) for pentosan polysulfate sodium (PPS) for the treatment of approximately 10 patients with pain associated with knee osteoarthritis (KOA) with concurrent bone marrow lesions where patients have failed to respond to current standard of care.

A good case for commercial cannabis legalization in Africa

0
Legislation against cannabis is present in most African countries, although only a handful of governments actively prosecute marijuana growers and users. Most states with pro-cannabis laws only cater for its medicinal and export purposes

What is Delta-8 THC, and why are states issuing bans?

0
In addition to the recreational and alleged medicinal benefits of Delta-8 THC, one more thing made it appealing to consumers before the recent wave to ban it engulfed the nation. Delta-8 THC is synthesized from CBD, which is extracted from hemp. Why is this important?

New service tackles fatigue and performance in Australian workplaces

0
For a long time, fatigue management has almost exclusively been the realm of the attention critical industries but given the impact of the COVID-19 pandemic and the switch to working from home, we have seen an increase in fatigue-related stressors and incidents in office environments as well the workplace

Trajan acquires personalised blood testing business to strengthen data-based preventative healthcare

0
Trajan Scientific and Medical(Trajan) has completed the acquisition of the MyHealthTest blood testing service. The acquisition further boosts Trajan’s ability to deliver analytical measurement...

FOLLOW US ON TWITTER

264FollowersFollow